Rocket Pharmaceuticals Shares Are Trading Lower After the Company Announced a $165 Million Upsized Public Offering of 13.2 Million Shares at $12.50 per Share.
Rocket Pharmaceuticals Shares Are Trading Lower After the Company Announced a $165 Million Upsized Public Offering of 13.2 Million Shares at $12.50 per Share.
Rocket Pharmaceuticals的股票在公司宣布以每股12.50美元发行1320万股、总计16500万美元的增资公开发行后，交易价格下跌。
Rocket Pharmaceuticals Shares Are Trading Lower After the Company Announced a $165 Million Upsized Public Offering of 13.2 Million Shares at $12.50 per Share.
Rocket Pharmaceuticals的股票在公司宣布以每股12.50美元发行1320万股、总计16500万美元的增资公开发行后，交易价格下跌。
热门讨论
FOMC维持利率但不确定性高企：美股后市走向如何？
🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？
Moo Live
03/20 02:25
联邦公开市场委员会新闻发布会，2025年3月19日